Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7241
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study ; volume:34 ; number:4 ; day:4 ; month:5 ; year:2020 ; pages:515-523 ; date:8.2020
Cardiovascular drugs and therapy ; 34, Heft 4 (4.5.2020), 515-523, 8.2020
- Urheber
-
Langslet, Gisle
Hovingh, G. Kees
Guyton, John R.
Baccara-Dinet, Marie T.
Letierce, Alexia
Manvelian, Garen
Farnier, Michel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10557-020-06984-0
- URN
-
urn:nbn:de:101:1-2020083119071569343081
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Langslet, Gisle
- Hovingh, G. Kees
- Guyton, John R.
- Baccara-Dinet, Marie T.
- Letierce, Alexia
- Manvelian, Garen
- Farnier, Michel
- SpringerLink (Online service)
Ähnliche Objekte (12)
P5.22: Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia
Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia
Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study
Familial Hypercholesterolemia: new therapeutic approaches
Sex Differences in Familial Hypercholesterolemia
Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
Familial Hypercholesterolemia: Present and Future Management
The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
Current causes of death in familial hypercholesterolemia
Familial hypercholesterolemia in very young myocardial infarction
Deploying Clinical Decision Support for Familial Hypercholesterolemia
R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study
P5.22: Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia
Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia
Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study
Familial Hypercholesterolemia: new therapeutic approaches
Sex Differences in Familial Hypercholesterolemia
Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
Familial Hypercholesterolemia: Present and Future Management
The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
Current causes of death in familial hypercholesterolemia
Familial hypercholesterolemia in very young myocardial infarction
Deploying Clinical Decision Support for Familial Hypercholesterolemia
R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study
P5.22: Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia
Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia
Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study
Familial Hypercholesterolemia: new therapeutic approaches
Sex Differences in Familial Hypercholesterolemia
Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
Familial Hypercholesterolemia: Present and Future Management
The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
Current causes of death in familial hypercholesterolemia
Familial hypercholesterolemia in very young myocardial infarction
Deploying Clinical Decision Support for Familial Hypercholesterolemia